Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEZLOTOXUMAB vs BICALUTAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEZLOTOXUMAB vs BICALUTAMIDE: Safety Overview

Metric BEZLOTOXUMAB BICALUTAMIDE
Total FAERS Reports 310 4,061
Deaths Reported 59 462
Death Rate 19.0% 11.4%
Hospitalizations 88 1,486
Average Patient Age 68.1 yrs 71.9 yrs
% Female Patients 68.5% 2.1%
FDA Approval Date N/A Aug 28, 2009
Manufacturer Merck Sharp & Dohme LLC Proficient Rx LP
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription